sarnsrun/medquad huggingface dataset:
Topic: Childhood Brain Stem Glioma
Question: How to diagnose Childhood Brain Stem Glioma ?
Answer: Tests that examine the brain are used to detect (find) childhood brain stem glioma. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Neurological exam : A series of questions and tests to check the brain, spinal cord, and nerve function. The exam checks a persons mental status, coordination, and ability to walk normally, and how well the muscles, senses, and reflexes work. This may also be called a neuro exam or a neurologic exam.     -   MRI (magnetic resonance imaging) with gadolinium : A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the brain. A substance called gadolinium is injected into a vein. The gadolinium collects around the cancer cells so they show up brighter in the picture. This procedure is also called nuclear magnetic resonance imaging (NMRI).
                    - A biopsy may be done to diagnose certain types of brain stem glioma. If the MRI scan looks like the tumor is a DIPG, a biopsy is usually not done and the tumor is not removed.    If the MRI scan looks like a focal brain stem glioma, a biopsy may be done. A part of the skull is removed and a needle is used to remove a sample of the brain tissue. Sometimes, the needle is guided by a computer. A pathologist views the tissue under a microscope to look for cancer cells. If cancer cells are found, the doctor will remove as much tumor as safely possible during the same surgery.    The following test may be done on the tissue that was removed:         -   Immunohistochemistry : A test that uses antibodies to check for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the tissue to light up under a microscope. This type of test may be used to tell the difference between brain stem glioma and other brain tumors.
Source: CancerGov
Topic: Childhood Brain Stem Glioma
Question: What is the outlook for Childhood Brain Stem Glioma ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis and treatment options depend on:         - The type of brain stem glioma.    - Where the tumor is found in the brain and if it has spread within the brain stem.    - The age of the child when diagnosed.    - Whether or not the child has a condition called neurofibromatosis type 1.    - Whether the tumor has just been diagnosed or has recurred (come back).
Source: CancerGov
Topic: Childhood Brain Stem Glioma
Question: What are the stages of Childhood Brain Stem Glioma ?
Answer: Key Points
                    - The plan for cancer treatment depends on whether the tumor is in one area of the brain or has spread all through the brain.
                
                
                    The plan for cancer treatment depends on whether the tumor is in one area of the brain or has spread all through the brain.
                    Staging is the process used to find out how much cancer there is and if cancer has spread. It is important to know the stage in order to plan treatment.    There is no standard staging system for childhood brain stem glioma. Treatment is based on the following:         - Whether the tumor is newly diagnosed or recurrent (has come back after treatment).    - The type of tumor (either a diffuse intrinsic pontine glioma or a focal glioma).
Source: CancerGov
Topic: Childhood Brain Stem Glioma
Question: what research (or clinical trials) is being done for Childhood Brain Stem Glioma ?
Answer: New types of treatment are being tested in clinical trials.
                 Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Source: CancerGov
Topic: Colorectal Cancer
Question: What is (are) Colorectal Cancer ?
Answer: Key Points
                    - Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.     - Colorectal cancer is the second leading cause of death from cancer in the United States.     - Different factors increase or decrease the risk of getting colorectal cancer.
                
                
                    Colorectal cancer is a disease in which malignant (cancer) cells form in the tissues of the colon or the rectum.
                    The colon and rectum are parts of the body's digestive system. The digestive system removes and processes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from foods and helps pass waste material out of the body. The digestive system is made up of the mouth, throat, esophagus, stomach, and the small and large intestines. The colon (large bowel) is the first part of the large intestine and is about 5 feet long. Together, the rectum and anal canal make up the last part of the large intestine and are 6-8 inches long. The anal canal ends at the anus (the opening of the large intestine to the outside of the body).      Cancer that begins in the colon is called colon cancer, and cancer that begins in the rectum is called rectal cancer. Cancer that begins in either of these organs may also be called colorectal cancer.   See the following PDQ summaries for more information about colorectal cancer:         -   Colorectal Cancer Prevention     -  Colon Cancer Treatment     -  Rectal Cancer Treatment     -  Genetics of Colorectal Cancer
                
                
                    Colorectal cancer is the second leading cause of death from cancer in the United States.
                    The number of new colorectal cancer cases and the number of deaths from colorectal cancer are decreasing a little bit each year. But in adults younger than 50 years, there has been a small increase in the number of new cases each year since 1998. Colorectal cancer is found more often in men than in women.
Source: CancerGov
Topic: Colorectal Cancer
Question: Who is at risk for Colorectal Cancer? ?
Answer: Different factors increase or decrease the risk of getting colorectal cancer. Anything that increases your chance of getting a disease is called a risk factor. Anything that decreases your chance of getting a disease is called a protective factor.   For information about risk factors and protective factors for colorectal cancer, see the PDQ summary on Colorectal Cancer Prevention.
Source: CancerGov
Topic: Transitional Cell Cancer of the Renal Pelvis and Ureter
Question: What is (are) Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Answer: Key Points
                    - Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter.    -  Misuse of certain pain medicines can affect the risk of transitional cell cancer of the renal pelvis and ureter.     - Signs and symptoms of transitional cell cancer of the renal pelvis and ureter include blood in the urine and back pain.    - Tests that examine the abdomen and kidneys are used to detect (find) and diagnose transitional cell cancer of the renal pelvis and ureter.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Transitional cell cancer of the renal pelvis and ureter is a disease in which malignant (cancer) cells form in the renal pelvis and ureter.
                    The renal pelvis is the top part of the ureter. The ureter is a long tube that connects the kidney to the bladder. There are two kidneys, one on each side of the backbone, above the waist. The kidneys of an adult are about 5 inches long and 3 inches wide and are shaped like a kidney bean. Tiny tubules in the kidneys filter and clean the blood. They take out waste products and make urine. The urine collects in the middle of each kidney in the renal pelvis. Urine passes from the renal pelvis through the ureter into the bladder. The bladder holds the urine until it passes through the urethra and leaves the body.      The renal pelvis and ureters are lined with transitional cells. These cells can change shape and stretch without breaking apart. Transitional cell cancer starts in these cells. Transitional cell cancer can form in the renal pelvis or the ureter or both.    Renal cell cancer is a more common type of kidney cancer. See the PDQ summary about Renal Cell Cancer Treatment for more information.
Source: CancerGov
Topic: Transitional Cell Cancer of the Renal Pelvis and Ureter
Question: What are the symptoms of Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Answer: Signs and symptoms of transitional cell cancer of the renal pelvis and ureter include blood in the urine and back pain. These and other signs and symptoms may be caused by transitional cell cancer of the renal pelvis and ureter or by other conditions. There may be no signs or symptoms in the early stages. Signs and symptoms may appear as the tumor grows. Check with your doctor if you have any of the following:         - Blood in the urine.    - A pain in the back that doesn't go away.    - Extreme tiredness.    -  Weight loss with no known reason.     - Painful or frequent urination.
Source: CancerGov
Topic: Transitional Cell Cancer of the Renal Pelvis and Ureter
Question: How to diagnose Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Answer: Tests that examine the abdomen and kidneys are used to detect (find) and diagnose transitional cell cancer of the renal pelvis and ureter. The following tests and procedures may be used:          -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.    -   Urinalysis : A test to check the color of urine and its contents, such as sugar, protein, blood, and bacteria.    -   Ureteroscopy : A procedure to look inside the ureter and renal pelvis to check for abnormal areas. A ureteroscope is a thin, tube-like instrument with a light and a lens for viewing. The ureteroscope is inserted through the urethra into the bladder, ureter, and renal pelvis. A tool may be inserted through the ureteroscope to take tissue samples to be checked under a microscope for signs of disease.    -   Urine cytology : A laboratory test in which a sample of urine is checked under a microscope for abnormal cells. Cancer in the kidney, bladder, or ureter may shed cancer cells into the urine.    -   Intravenous pyelogram (IVP): A series of x-rays of the kidneys, ureters, and bladder to check for cancer. A contrast dye is injected into a vein. As the contrast dye moves through the kidneys, ureters, and bladder, x-rays are taken to see if there are any blockages.    -   CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.    -   Ultrasound : A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. An ultrasound of the abdomen may be done to help diagnose cancer of the renal pelvis and ureter.    -   MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body, such as the pelvis. This procedure is also called nuclear magnetic resonance imaging (NMRI).    -   Biopsy : The removal of cells or tissues so they can be viewed under a microscope by a pathologist to check for signs of cancer. This may be done during a ureteroscopy or surgery.
Source: CancerGov
Topic: Transitional Cell Cancer of the Renal Pelvis and Ureter
Question: What is the outlook for Transitional Cell Cancer of the Renal Pelvis and Ureter ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends on the stage and grade of the tumor.   The treatment options depend on the following:         - The stage and grade of the tumor.    -  Where the tumor is.    - Whether the patient's other kidney is healthy.    - Whether the cancer has recurred.        Most transitional cell cancer of the renal pelvis and ureter can be cured if found early.
Source: CancerGov
Topic: Gestational Trophoblastic Disease
Question: Who is at risk for Gestational Trophoblastic Disease? ?
Answer: Age and a previous molar pregnancy affect the risk of GTD. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk to your doctor if you think you may be at risk. Risk factors for GTD include the following:         - Being pregnant when you are younger than 20 or older than 35 years of age.     - Having a personal history of hydatidiform mole.
Source: CancerGov
Topic: Gestational Trophoblastic Disease
Question: What are the symptoms of Gestational Trophoblastic Disease ?
Answer: Signs of GTD include abnormal vaginal bleeding and a uterus that is larger than normal. These and other signs and symptoms may be caused by gestational trophoblastic disease or by other conditions. Check with your doctor if you have any of the following:         -  Vaginal bleeding not related to menstruation.    -  A uterus that is larger than expected during pregnancy.    - Pain or pressure in the pelvis.    - Severe nausea and vomiting during pregnancy.    - High blood pressure with headache and swelling of feet and hands early in the pregnancy.    - Vaginal bleeding that continues for longer than normal after delivery.    -  Fatigue, shortness of breath, dizziness, and a fast or irregular heartbeat caused by anemia.        GTD sometimes causes an overactive thyroid. Signs and symptoms of an overactive thyroid include the following:         - Fast or irregular heartbeat.    - Shakiness.    - Sweating.    - Frequent bowel movements.    - Trouble sleeping.    - Feeling anxious or irritable.    - Weight loss.
Source: CancerGov
Topic: Gestational Trophoblastic Disease
Question: How to diagnose Gestational Trophoblastic Disease ?
Answer: Tests that examine the uterus are used to detect (find) and diagnose gestational trophoblastic disease. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.     -   Pelvic exam : An exam of the vagina, cervix, uterus, fallopian tubes, ovaries, and rectum. A speculum is inserted into the vagina and the doctor or nurse looks at the vagina and cervix for signs of disease. A Pap test of the cervix is usually done. The doctor or nurse also inserts one or two lubricated, gloved fingers of one hand into the vagina and places the other hand over the lower abdomen to feel the size, shape, and position of the uterus and ovaries. The doctor or nurse also inserts a lubricated, gloved finger into the rectum to feel for lumps or abnormal areas.    -   Ultrasound exam of the pelvis: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs in the pelvis and make echoes. The echoes form a picture of body tissues called a sonogram. Sometimes a transvaginal ultrasound (TVUS) will be done. For TVUS, an ultrasound transducer (probe) is inserted into the vagina to make the sonogram.     -   Blood chemistry studies : A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease. Blood is also tested to check the liver, kidney, and bone marrow.     -   Serum tumor marker test : A procedure in which a sample of blood is checked to measure the amounts of certain substances made by organs, tissues, or tumor cells in the body. Certain substances are linked to specific types of cancer when found in increased levels in the body. These are called tumor markers. For GTD, the blood is checked for the level of beta human chorionic gonadotropin (-hCG), a hormone that is made by the body during pregnancy. -hCG in the blood of a woman who is not pregnant may be a sign of GTD.    -   Urinalysis : A test to check the color of urine and its contents, such as sugar, protein, blood, bacteria, and the level of -hCG.
Source: CancerGov
Topic: Gestational Trophoblastic Disease
Question: What is the outlook for Gestational Trophoblastic Disease ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. Gestational trophoblastic disease usually can be cured. Treatment and prognosis depend on the following:         - The type of GTD.    - Whether the tumor has spread to the uterus, lymph nodes, or distant parts of the body.    - The number of tumors and where they are in the body.    - The size of the largest tumor.    - The level of -hCG in the blood.    - How soon the tumor was diagnosed after the pregnancy began.    - Whether GTD occurred after a molar pregnancy, miscarriage, or normal pregnancy.    - Previous treatment for gestational trophoblastic neoplasia.        Treatment options also depend on whether the woman wishes to become pregnant in the future.
Source: CancerGov
Topic: Gestational Trophoblastic Disease
Question: what research (or clinical trials) is being done for Gestational Trophoblastic Disease ?
Answer: New types of treatment are being tested in clinical trials.
                    Information about ongoing clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
Source: CancerGov
Topic: Chronic Myelogenous Leukemia
Question: What is (are) Chronic Myelogenous Leukemia ?
Answer: Chronic myelogenous leukemia is a disease in which too many white blood cells are made in the bone marrow. See the PDQ summary on Chronic Myelogenous Leukemia Treatment for information on diagnosis, staging, and treatment.
Source: CancerGov
Topic: Chronic Myelogenous Leukemia
Question: What are the treatments for Chronic Myelogenous Leukemia ?
Answer: See the PDQ summary about Chronic Myelogenous Leukemia Treatment for information.
Source: CancerGov
Topic: Lung Cancer
Question: What is (are) Lung Cancer ?
Answer: Key Points
                    - Lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.    - Lung cancer is the leading cause of cancer death in the United States.    - Different factors increase or decrease the risk of lung cancer.
                
                
                    Lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
                    The lungs are a pair of cone-shaped breathing organs inside the chest. The lungs bring oxygen into the body when breathing in and send carbon dioxide out of the body when breathing out. Each lung has sections called lobes. The left lung has two lobes. The right lung, which is slightly larger, has three. A thin membrane called the pleura surrounds the lungs. Two tubes called bronchi lead from the trachea (windpipe) to the right and left lungs. The bronchi are sometimes involved in lung cancer. Small tubes called bronchioles and tiny air sacs called alveoli make up the inside of the lungs.      There are two types of lung cancer: small cell lung cancer and non-small cell lung cancer.    See the following PDQ summaries for more information about lung cancer:         -   Lung Cancer Prevention     -  Non-Small Cell Lung Cancer Treatment     -  Small Cell Lung Cancer Treatment
                
                
                    Lung cancer is the leading cause of cancer death in the United States.
                    Lung cancer is the third most common type of non-skin cancer in the United States. Lung cancer is the leading cause of cancer death in men and in women.
Source: CancerGov